|
Press releases
Bruxelles, le 13 juillet 2000
Brussels, 13 July 2000
Commission
takes initiative to restore confidence in GMO approval
process
The European Commission decided
yesterday to propose to Member States a strategy to
regain public trust in the approval procedure for
Genetically Modified Organisms (GMOs). The objective is
to resume the authorisation process for GMOs in the
near future whilst addressing public concerns on GMOs
as well as problems of legal uncertainty for
stakeholders. The Commission wants to give a clear
response to political and legal concerns over GMOs
which favours consumer choice and legal certainty. The
Commission calls upon the Member States to play their
part in paving the way for a clearer and more
comprehensive GMO strategy in Europe in the future and
promoting an open public debate. The Commission
proposes to apply the key provisions on the revised
directive on the release of GMOs in the environment to
all new GMO approvals after agreement on its content
has been reached between the Council and the European
Parliament. The conciliation procedure is due to start
on the 19 September. Further measures on labelling and
traceability of GMOs will be put forward in the
autumn.
The Commission's strategy aims to enable
the relaunch of authorisations of GMO products on the basis
of a reinforced framework for approvals. It entails the
following:
- Anticipating the key provisions
(labelling, traceability, monitoring etc) of the revised
Directive 90/220 before they are transposed in all Member
States. The new requirements will be incorporated into the
individual authorisations of GMO products granted on the
basis of the existing Directive 90/220. The notifying
companies will need to put forward voluntarily commitments
in line with the new requirements as part of their
applications for authorisation. Such commitments would
become legally binding when the authorisation is granted.
Authorisations would be time-limited and control of
approved products reinforced.
- A comprehensive set of labelling
provisions which would cover GMOs and GMO products to be
submitted by the Commission by autumn 2000
- An initiative on a traceability system
for GMOs to be submitted by the Commission by autumn
2000
- Acceleration of work on related
issues. This includes environmental liability, the
monitoring and study of possible long-term effects on
biodiversity; further research; as well as taking into
account international developments (i.e. Biosafety
Protocol)
The Commission firmly believes that it
is crucial to all stakeholders to assume their
responsibilities and adopt a comprehensive perspective on
the issue of GMO authorisations.
Commenting on the Commission's debate,
Environment Commissioner Margot Wallström stated:
"The Commission in its discussion
acknowledged that there is a need for political leadership
to take forward the debate on GMOs in the EU. We are ready
to take up that challenge, together with Member States. The
approach proposed by the Commission is a first step towards
a more constructive and responsible strategy on GMOs." She
added: "Our role is first and foremost to provide a
framework for the authorisation and control of GMOs, which
is reliable and safe for consumers and the environment. We
need to re-establish confidence in our approval systems.
Citizens must be allowed to chose for themselves whether
they want products containing GMOs or not."
David Byrne, Commissioner for Health and
Consumer Protection said: "The objective of the Commission
is to promote a balanced approach to biotechnology and GMOs
in particular. The public needs to be assured of the
highest protection of public health, and of the
environment, including the protection of biodiversity. At
the same time they need to be able to make an informed
choice with regard to GMO products. I want to emphasise
that our approval system is strictly science-based.
Consumers should be assured and informed that we are paying
attention to all questions they have raised."
With this approach, the Commission
wishes to signal to Member States, other Community
institutions, trading partners and civil society that it is
necessary to respond to public concern with concrete
action. Not to act does not constitute a solution, but
would leave the EU unprepared and lagging behind in the
handling of GMOs.
The new approach should make it possible
for Member States to act on a different and stronger basis
in the Regulatory Committee (consisting of representatives
of the Member States (considering products for approval
under Article 21 of Directive 90/220) as well as in the
Council, while restoring the confidence of consumers and
trading partners.
The Commission also believes it is
important to establish the conditions necessary for the
development of a sector that will play a crucial role in
the future economy and competitiveness of European
industry.
In its debate, the Commission stressed
the importance of maintaining the dialogue with all
stakeholders and interested parties - consumers,
agriculture, industry, NGOs, science, governments, European
Institutions and trading partners.
Background
(see also background MEMO/00/43)
GMOs and the use of modern biotechnology
in food and plants is currently the focus of intense public
and political debate. Growing concerns have particularly
focused on potential risks to human health and the
environment. A "de facto moratorium" applied by Member
States has implied that no new GM products have received
approval under the EU procedure since October 1998. Five
Member States have banned already approved GM products,
under Art 16 of Directive 90/220. This article enables
Member States to ban or restrict use/sale of specific GMO
products temporarily, on certain conditions.
Approvals of GMO products in the EU is
based on both general and specific legislation. 18 products
have been approved to date under the general Directive
(Directive 90/220/CEE), while 14 are pending approval. This
Directive is currently under revision. The second reading
in the European Parliament was completed in April, and a
conciliation procedure between Council and European
Parliament is scheduled to be launched on 19
September.
Rapid agreement between the European
Parliament and the Council could result in adoption of the
revised Directive by autumn 2000 with transposition in
national law by spring 2002.
Pia Ahrenkilde : 02/299.12.23
Beate Gminder : 02/296.56.94
Andrea Dahmen : 02/296.04.86
Catherine Bunyan : 02/299.65.12
Lone Mikkelsen : 02/296.05.67
Released on 13/07/2000
Press releases
FOOD SAFETY |
PUBLIC
HEALTH |
CONSUMER
PROTECTION |
DIRECTORATE GENERAL "HEALTH
& CONSUMER PROTECTION"
|